iShares Biotechnology ETF $IBB Shares Purchased by Endowment Wealth Management Inc.

Endowment Wealth Management Inc. increased its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 30.4% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 4,585 shares of the financial services provider’s stock after acquiring an additional 1,070 shares during the quarter. Endowment Wealth Management Inc.’s holdings in iShares Biotechnology ETF were worth $580,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. Ramirez Asset Management Inc. acquired a new stake in iShares Biotechnology ETF during the first quarter worth approximately $26,000. Berkshire Money Management Inc. purchased a new position in iShares Biotechnology ETF during the second quarter worth approximately $28,000. Financial Gravity Asset Management Inc. purchased a new position in iShares Biotechnology ETF during the first quarter worth approximately $30,000. Woodside Wealth Management LLC purchased a new position in iShares Biotechnology ETF during the first quarter worth approximately $31,000. Finally, CX Institutional purchased a new position in iShares Biotechnology ETF during the first quarter worth approximately $32,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 1.4%

NASDAQ:IBB opened at $149.95 on Monday. iShares Biotechnology ETF has a fifty-two week low of $107.43 and a fifty-two week high of $153.01. The firm’s 50 day moving average is $140.94 and its two-hundred day moving average is $130.59.

iShares Biotechnology ETF Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, September 19th. Shareholders of record on Tuesday, September 16th were paid a dividend of $0.0828 per share. The ex-dividend date of this dividend was Tuesday, September 16th. This represents a $0.33 dividend on an annualized basis and a yield of 0.2%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.